Correlation Between Bristol-Myers Squibb and COVER
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and COVER at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and COVER into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and COVER, you can compare the effects of market volatilities on Bristol-Myers Squibb and COVER and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of COVER. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and COVER.
Diversification Opportunities for Bristol-Myers Squibb and COVER
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Bristol-Myers and COVER is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and COVER in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COVER and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with COVER. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COVER has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and COVER go up and down completely randomly.
Pair Corralation between Bristol-Myers Squibb and COVER
Assuming the 90 days horizon Bristol-Myers Squibb is expected to generate 1.6 times less return on investment than COVER. In addition to that, Bristol-Myers Squibb is 1.22 times more volatile than COVER. It trades about 0.22 of its total potential returns per unit of risk. COVER is currently generating about 0.42 per unit of volatility. If you would invest 1,220 in COVER on September 1, 2024 and sell it today you would earn a total of 488.00 from holding COVER or generate 40.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 86.96% |
Values | Daily Returns |
Bristol Myers Squibb vs. COVER
Performance |
Timeline |
Bristol Myers Squibb |
COVER |
Bristol-Myers Squibb and COVER Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bristol-Myers Squibb and COVER
The main advantage of trading using opposite Bristol-Myers Squibb and COVER positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, COVER can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COVER will offset losses from the drop in COVER's long position.Bristol-Myers Squibb vs. Novartis AG | Bristol-Myers Squibb vs. Bayer AG | Bristol-Myers Squibb vs. Astellas Pharma | Bristol-Myers Squibb vs. Roche Holding AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |